Skip to Content



Definition: An oral epidermal growth factor receptor (EGFR) inhibitor used in the treatment of malignancies with either mutated or overactive EGFR; most commonly used in treatment of lung cancers.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.